MSB

7.69%

$1.19 mesoblast limited

I suggest as much three months ago, but no one commented at that...

First 617 Last

Share
Profile

Follow
bundeenabuoy

54 Posts.

3

09/10/20

21:08

Post #: 47989096
Share

Originally posted by dolcevita: ↑

The only thing that does is that EITHER: (a) MSB misread (due to inexperience, naivete, over-reading into ambiguous messages, etc., etc.) the signals that the FDA was sending; OR, more worryingly, (b) the FDA had an agenda (perhaps to make a clear example to the industry and the public that stem cells were NOT going to get an easy ride) that was not fully disclosed to MSB, and which only really came to light with the issuance of the ODAC briefing packet, with the apotheosis in the CRL.

I think it's Occam's Razor at this point. The FDA is simply out of their depth. They haven't given consistent signals, certainly that's a feature of their problem which they're making into MSB's problem.

stem cells were NOT going to get an easy rideMSB has NOT had an easy ride! Far from it!

The lack of appropriate guidelines and protocols (because they were drug focussed) meant MSB and Teva (then partners) had to show the FDA how it's done and they did it collaboratively. Progress has been grindingly slow. The shared intention was to eliminate the cowboys who DO want an easy ride. Please read back on this. SI has been an adviser on this. I spoke with him years ago about the regulatory barriers, and he was well aware of the issues.

But you cannot plan for capriciousness. I've seen this fear and not reason-based mentality in the public service firsthand but naturally I cannot go into it. It also exists in private enterprise but they have other tendencies, viz. to be ultra risky, and that's where the rogue operators are.

The FDA simply do not understand what they have here and they are in danger of making utter goats of themselves and being responsible for needless deaths. (Not that it's a problem in the Trump era, things have become so warped about conflict of interest and corruption that 200k+ deaths do not register).

There are signs that the America First mentality could be behind it and stalling for a competitor to catch up, but that's only a possibility. We cannot absolutely rule it out with this administration. Unlike Australia the public service is highly politicised. The FDA should be independent but there are no guarantees that this is what is occurring here. It's murky.

Expand

I suggest as much three months ago, but no one commented at that time.

MSB Price at posting: $3.37 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

Bitcoin investors need to know the risks

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

There are more pages in this discussion • 401 more messages in this thread...

First 617 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.19		Change 0.085(7.69%)		Mkt cap ! $1.358B

Open	High	Low	Value	Volume
$1.10	$1.20	$1.09	$13.21M	11.37M

Buyers (Bids)

No.	Vol.	Price($)
1	15000	$1.19

Sellers (Offers)

Price($)	Vol.	No.
$1.19	75212	5

View Market Depth

No.	Vol.	Price($)
1	15000	1.185
1	20000	1.175
1	5664	1.170
1	17568	1.160
3	56695	1.150

Price($)	Vol.	No.
1.190	59712	2
1.195	36255	5
1.200	404381	31
1.205	3000	1
1.210	162475	7

Last trade - 16.10pm 12/07/2024 (20 minute delay)

MSB (ASX) Chart

I suggest as much three months ago, but no one commented at that...

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Nimy to raise $1.21M to explore 'newsy' WA targets

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Immutep reports strong response rate from immunotherapies treating carcinomas

Bitcoin investors need to know the risks

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I suggest as much three months ago, but no one commented at that...

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Nimy to raise $1.21M to explore 'newsy' WA targets

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Immutep reports strong response rate from immunotherapies treating carcinomas

Bitcoin investors need to know the risks

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News